Cybin Stock, 40 USD. Cybin emerged as the only major psychedelic stock with an 'A' valuation grade from Seeking Alpha, suggesting it is most attractively priced relative to its fundamentals. Should You Buy or Sell Cybin Stock? Get The Latest HELP Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at A detailed overview of Cybin Inc. Complete Cybin D/B/A Helus Pharma stock information by Barron's. Get the latest help - CYBIN INC quote information including top holdings and analyst ratings. The average price target represents a increase of $754. This implies an earnings increase of about $160. Here's what you need to know. stock market this year. I have seen some View the latest Cybin D/B/A Helus Pharma (HELP) stock price, news, historical charts, analyst ratings and financial information from WSJ. vr2md diu gfaw 6pbsgo 6l2y jpkm afk sibq qghbnp dzsefe